Recent advances in cyclic-adenosine monophosphate/protein kinase A signaling in ethanol-induced synaptic and behavioral alterations

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 7, 2004, Pages 1129-1136

  Chandler, L Judson ^a,e   Bonci, Antonello ^b   Wand, Gary S ^d   Morrisett, Richard A ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cyclic Adenosine Monophosphate; DARPP 32; Dopamine; Ethanol; NMDA Receptors; Nucleus Accumbens; Protein Kinase A; Ventral Tegmental Area

Indexed keywords

ALCOHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN DARPP 32;

ALCOHOL CONSUMPTION; ALCOHOLISM; BEHAVIORAL MEDICINE; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; GABAERGIC SYSTEM; GENETIC TRANSCRIPTION; IN VIVO STUDY; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REGULATORY MECHANISM; SEDATION; SIGNAL TRANSDUCTION; SYMPOSIUM; SYNAPTIC TRANSMISSION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ETHANOL; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 3242660022     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000131980.53097.11     Document Type: Conference Paper

References (47)

1. Abel T, Kandel E (1998) Positive and negative regulatory mechanisms that mediate long-term memory storage. Brain Res Brain Res Rev 26:360-378.
2. Abel T, Nguyen PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R (1997) Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88:615-626.
3. Biala G, Kotlinska J (1999) Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Alcohol Alcohol 34:175-182.
4. Bonci A, Williams JT (1997) Increased probability of GABA release during withdrawal from morphine. J Neurosci 17:796-803.
5. Camarini R, Mehmert KK, Hodge CW (2000) Effects of ethanol pre-exposure on ethanol self-administration in DBA/2J and C57BL/6 mice. Alcohol Clin Exp Res (Suppl) 24:16A.
6. Chandler LJ, Harris RA, Crews FT (1998) Ethanol tolerance and synaptic plasticity. Trends Pharmacol Sci 19:491-495.
7. Chandler LJ (2003) Ethanol and brain plasticity: receptors and molecular networks of the postsynaptic density as targets of ethanol. Pharmacol Therapeut 99:311-326.
8. Crews FT, Rudolph JG, Chandler LJ (2002) Glutamate and alcohol-induced neurotoxicity, in Contemporary Clinical Neuroscience: Glutamate and Addiction (Herman BH, Frankenheim J, Litten R, Sheridan PH, Weight FF, Zukin SR, eds) pp 357-373. Humana Press Totowa, NJ.
9. Crump FT, Dillman KS, Craig AM (2001) cAMP-Dependent protein kinase mediates activity-regulated synaptic targeting of NMDA receptors. J Neurosci 21:5079-5088.
10. Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B (1991) A genetic study of platelet adenylate cyclase activity: evidence for a single major locus effect in fluoride-stimulated activity. Am J Hum Genet 49:372-377.
11. Diana M, Pistis M, Muntoni AL, Gessa GL (1996) Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence. Neurosci 71:411-415.
12. El-Ghundi M, George SR, Drago J, Fletcher PJ, Fan T, Nguyen T, Liu C, Sibley DR, Westphal H, O'Dowd BF (1998) Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior. Eur J Pharmacol 353:149-158.
13. Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: from neuro-adaptation to neurodegeneration. Prog Neurobiol 56:385-431.
14. Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P (1998) DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science (Wash. DC) 281:838-842.
15. Forget MA, Sisson JH, Spurzem JR, Wyatt TA (2003) Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells. Alcohol 31:31-38.
16. Files FJ, Samson HH, Denning CE (2000) Effects of prior ethanol exposure on ethanol self-administration in a continuous access situation using retractable drinking tubes. Alcohol 2197-102.
17. Foroud T, Li T-K (1999) Genetics of alcoholism: a review of recent studies in human and animal models. Am J Addict 8:261-278.
18. Froehlich JC, Wand GS (1997) Adenylyl cyclase signal transduction and alcohol-induced sedation. Pharmacol Biochem Behav 58:1021-1030.
19. Gordon AS, Krauss SW, Nagy L, Diamond I (1991) Nucleoside transport in lymphocytes from alcoholics and non-alcoholics. Adv Exp Med Biol 309A:387-390.
20. Grant KA, Knisely JS, Tabakoff B, Barrett JE, Balster RL (1991) Ethanol-like discriminative stimulus effects on non-competitive N-methyl-D-aspartate antagonists. Behav Pharmacol 2:87-95.
21. Hemmings JHC, Greengard P, Tung HYL, Cohen P (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature (Lond.) 310:503-505.
22. Hoffman PL, Rabe CS, Moses F, Tabakoff B (1989) N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 52:1937-1940.
23. Hoffman PL, Tabakoff B (1990) Ethanol and guanine nucleotide binding proteins: a selective interaction. FASEB J 4:2612-2622.
24. Lovinger DM, White G, Weight, FF (1989) Ethanol inhibits NMDA-activated ion currents in hippocampal neurons. Science (Wash. DC) 243:1721-1724.
25. Maldve RE, Zhang TA, Ferrani-Kile K, Schreiber SS, Lippmann MJ, Snyder GL, Fienberg AA, Leslie SW, Gonzales RA, Morrisett RA (2002) DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens. Nat Neurosci 5:641-648.
26. Menninger JA, Baron AE, Tabakoff B (1998) Effects of abstinence and family history for alcoholism on platelet adrenyl cyclase activity. Alcohol Clin Exp Res 22:1955-1961.
27. Morrisett RA, Swartzwelder HS (1993) Attenuation of hippocampal long-term potentiation by ethanol: a patch clamp analysis of glutamatergic and GABAergic mechanisms. J Neurosci 13:2264-2272.
28. Nestler EJ (2001) Total recall-the memory of addiction. Science (Wash. DC) 292:2266-2267.
29. Nowak KL, McBride WJ, Lumeng L, Li T-K., Murphy JM (1998) Blocking GABAA receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol- preferring P rats. Psychopharmacology 139:108-116.
30. Parsian A, Todd RD, Cloninger CR, Hoffman PL, Ovichinnikova L, Ikeda H, Tabakoff B (1996) Platelet adrenyl cyclase activity in alcoholics and subtypes of alcoholics. WHO/ISBRA Study Clinical Centers. Alcohol Clin Exp Res 20:745-751.
31. Rao A, Craig AM (1997) Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron 19:801-812.
32. Risinger FO, Freeman PA, Greengard P, Fienberg AA (2001) Motivational effects of ethanol in DARPP-32 knock-out mice. J Neurosci 21:340-348.
33. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ (1998) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 18:1848-1859.
34. Smith BR, Robidoux J, Amit Z (1992) GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats. Alcohol Alcohol 27:227-231.
35. Snyder GL, Fienberg AA, Huganier RL, Greengard P (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulated dephosphorylation of the NMDA receptor. J Neurosci 18:10297-10303.
36. Spanagel R, Weiss F (1999) The dopamine hypothesis of reward: past and current status. Trends Neurosci 22:521-527.
37. Tabakoff B, Hoffman PL, Lee JM, Saito T, Willard B, Leon-Jones F (1988) Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med 318:134-139.
38. Thomas MP, Monaghan DT, Morrisett RA (1998) Evidence for a causative role of NMDA receptors in an in vitro model of alcohol withdrawal hyperexcitability. J Pharmacol Exp Ther 287:87-97.
39. Thomas MP, Morrisett RA (2000) Dynamics of NMDAR-mediated neurotoxicity during chronic ethanol exposure and withdrawal. Neuropharmacology 39:218-226.
40. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49:173-184.
41. Ungless MA, Whistler JL, Malenka RC, Bonci A (2001) Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (Lond.) 411:583-587.
42. Vorel SR, Liu X, Hayes RJ, Spector JA, Gardner EL (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science (Wash. DC) 292:1175-1178.
43. Waltman C, Levine MA, McCaul ME, Svikis DS, Wand GS (1993) Enhanced expression of the inhibitory protein Gi2 alpha and decreased activity of adenylyl cyclase in lymphocytes of abstinent alcoholics. Alcohol Clin Exp Res 17:315-320.
44. Wand GS, Waltman C, Martin CS, McCaul ME, Levine MA, Wolfgang D (1994) Differential expression of guanosine triphosphate binding proteins in men at high and low risk for the future development of alcoholism. J Clin Invest 94:1004-1011.
45. Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13-22.
46. Woodward JJ (2000) Ethanol and NMDA receptor signaling. Crit Rev Neurobiol 14:68-89.
47. Zhang H-T, Crissman AM, Dorairaj NR, Chandler LJ, O'Donnell JM (2000) Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism. Neuropsychopharmacology 23:198-204.